← boothcheck

Is CRI overvalued?

boothcheck doesn't label CRI overvalued or undervalued, and it doesn't publish a fair value. It shows what the price assumes instead. At today's price, CRI is priced for an operating margin near 4.9% versus the 3.3% it earns today. The price is justified by relative-multiple and growth-DCF; earnings-power land below the price. The more the price assumes beyond what Carter's, Inc. has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from Carter's, Inc.'s SEC EDGAR filings via a reverse-DCF inversion. Last analyzed June 27, 2026.

Implied growth
For about
Margin needed4.9%
Margin today3.3%
Price vs asset value1.38x
Price vs earnings power2.14x
Price vs peer multiples0.66x
Price vs forward growth1.05x
Read the full CRI report →
Get boothcheck's read on what CRI's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.